FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel derivatives of pyrimidine of the general formula (I): 
or its pharmaceutically acceptable salts or esters hydrolyzed in vivo and possessing properties of selective inhibitor of cyclin-dependent kinases, such as CDK-2, and inhibiting proliferation of cells. Compounds can be used in preparing medicinal agents used in treatment of cancer diseases. In compounds of the formula (I) R1 represents halogen atom; p = 0 or 1; R2 represents sulfamoyl or group B-E-; q = 0 or 1 wherein p + q = 1; R3 represents hydrogen atom, (C1-C6)-alkyl wherein R3can be substituted optionally at carbon atom with one or some M; R4 represents (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C3-C8)-cycloalkyl wherein R4 can be substituted optionally with one or some M; or R3 and R4 taken with nitrogen atom to which they are bound form heterocyclic ring substituted optionally at carbon atom with one or some M wherein if indicated heterocyclic ring comprises group -NH then nitrogen atom can be substituted optionally with group chosen from Q; B is chosen from (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C3-C8)-cycloalkyl, (C3-C8)-cycloalkyl-(C1-C6)-alkyl, phenyl-(C1-C6)-alkyl or (heterocyclic group)-(C1-C6)-alkyl wherein B can be substituted optionally at carbon atom with one or some D and wherein indicated heterocyclic group comprises group -NH- then nitrogen atom can be substituted optionally with group chosen from G; E represents -S(O)r- or -N(Ra)SO2- wherein Ra represents hydrogen atom or (C1-C6)-alkyl and r = 2; D is chosen independently from halogen atom, nitro-, cyano-, hydroxy-, amino-group, (C1-C6)-alkyl, (C1-C6)-alkoxy-, N-(C1-C6)-alkylamino-, N,N-((-C1-C6)-alkyl)2-amino-, (C1-C6)-alkanoylamino-group, (C1-C6)-alkyl-S(O)a wherein a = 0-2, wherein D can be substituted optionally at carbon atom with one or some V; M is chosen independently from halogen atom, nitro-, cyano-, hydroxy-group, (C1-C6)-alkyl, (C1-C6)-alkoxy-, N,N-((C1-C6)-alkyl)2-amino-group, (C1-C6)-alkoxycarbonyl, (C3-C8)-cycloalkyl or heterocyclic group wherein M can be substituted optionally at carbon atom with one or some P; P, X and Y are chosen independently from hydroxy-group, methyl, methoxy-, dimethylamino-group; G and Q are chosen independently from (C1-C4)-alkyl, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl wherein Q can be substituted optionally at carbon atom with one or some X. Also, invention relates to methods for synthesis of compounds, preparing pharmaceutical compositions based on thereof and to a method for inhibition of proliferation of cells.
EFFECT: valuable medicinal properties of compounds and pharmaceutical compositions, improved method of inhibition, improved method of synthesis of compounds.
15 cl, 2 sch, 133 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDAQZOLO-5-YL-2-ANILINOPYRIMIDINES AS AGENTS FOR INHIBITION OF CELL PROLIFERATION, METHOD FOR THEIR PREPARING (VARIANTS), USING, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING | 2001 |
|
RU2284327C2 |
| IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLE[2,3-A]PYRIDINE DERIVATIVES | 2000 |
|
RU2248976C2 |
| INDOLIZINE DERIVATIVE AND ITS APPLICATION FOR MEDICAL PURPOSES | 2010 |
|
RU2529868C2 |
| TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING IT, POSSESSING ANALGESIC ACTIVITY | 2011 |
|
RU2565073C2 |
| IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
| SUBSTITUTED DERIVATIVES OF N-PHENYL-2-HYDROXY-2-METHYL-3,3,3-TRIFLUOROPROPANEAMIDE ENHANCING ACTIVITY OF PYRUVATE DEHYDROGENASE | 2000 |
|
RU2255085C2 |
| BICYCLIC DERIVATIVES, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, THEIR USING IN TREATMENT AND METHOD FOR TREATMENT OF MAMMALS BY THEIR USING | 2002 |
|
RU2310655C2 |
| HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2018 |
|
RU2797822C2 |
| PYRIMIDINE DERIVATIVES WITH ANTAGONIST PROPERTIES TOWARDS CRTH2(VERSIONS) | 2004 |
|
RU2361865C2 |
| HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2764243C2 |
